| Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma J Zhong, Y Ke, W Gong, L Ma, X Ye, T Peng, G Xie, L Li Annals of surgery 260 (2), 329-340, 2014 | 505 | 2014 |
| Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection AWH Chan, J Zhong, S Berhane, H Toyoda, A Cucchetti, KQ Shi, T Tada, ... Journal of hepatology 69 (6), 1284-1293, 2018 | 390 | 2018 |
| Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma YY Wang, JH Zhong, ZY Su, JF Huang, SD Lu, BD Xiang, L Ma, LN Qi, ... Journal of British Surgery 103 (6), 725-734, 2016 | 294 | 2016 |
| Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma LN Qi, BD Xiang, FX Wu, JZ Ye, JH Zhong, YY Wang, YY Chen, ZS Chen, ... Cancer research 78 (16), 4731-4744, 2018 | 237 | 2018 |
| Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization JH Zhong, BD Xiang, WF Gong, Y Ke, QG Mo, L Ma, X Liu, LQ Li PloS one 8 (7), e68193, 2013 | 184 | 2013 |
| Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion JH Zhong, AC Rodriguez, Y Ke, YY Wang, L Wang, LQ Li Medicine 94 (3), e396, 2015 | 146 | 2015 |
| Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: a meta‐analysis JH Zhong, LQ Li Hepatology Research 40 (10), 943-953, 2010 | 131 | 2010 |
| Systematic review comparing the safety and efficacy of conventional and drug‐eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma ZB Xie, XB Wang, YC Peng, SL Zhu, L Ma, BD Xiang, WF Gong, J Chen, ... Hepatology Research 45 (2), 190-200, 2015 | 100 | 2015 |
| Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials JH Zhong, H Li, LQ Li, XM You, Y Zhang, YN Zhao, JY Liu, BD Xiang, ... European Journal of Surgical Oncology (EJSO) 38 (4), 286-295, 2012 | 85 | 2012 |
| Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges JF Jiang, YC Lao, BH Yuan, J Yin, X Liu, L Chen, JH Zhong Oncotarget 8 (20), 33911, 2017 | 79 | 2017 |
| Efficacy of triclosan-coated sutures for reducing risk of surgical site infection in adults: a meta-analysis of randomized clinical trials J Guo, LH Pan, YX Li, XD Yang, LQ Li, CY Zhang, JH Zhong Journal of Surgical Research 201 (1), 105-117, 2016 | 77 | 2016 |
| Postoperative therapy options for hepatocellular carcinoma JH Zhong, L Ma, LQ Li Scandinavian journal of gastroenterology 49 (6), 649-661, 2014 | 72 | 2014 |
| Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study JH Zhong, NF Peng, XM You, L Ma, X Xiang, YY Wang, WF Gong, FX Wu, ... Oncotarget 8 (11), 18296, 2017 | 69 | 2017 |
| Aptamer-functionalized fluorescent silica nanoparticles for highly sensitive detection of leukemia cells J Tan, N Yang, Z Hu, J Su, J Zhong, Y Yang, Y Yu, J Zhu, D Xue, Y Huang, ... Nanoscale Research Letters 11, 1-8, 2016 | 68 | 2016 |
| Prognostic value of PD–L1 expression in patients with primary solid tumors X Xiang, PC Yu, D Long, XL Liao, S Zhang, XM You, JH Zhong, LQ Li Oncotarget 9 (4), 5058, 2018 | 67 | 2018 |
| Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy Y Ke, L Ma, XM You, SX Huang, YR Liang, BD Xiang, LQ Li, JH Zhong Cancer biology & medicine 10 (3), 158, 2013 | 66 | 2013 |
| Development and validation of a nomogram to preoperatively estimate post-hepatectomy liver dysfunction risk and long-term survival in patients with hepatocellular carcinoma YY Wang, BD Xiang, L Ma, JH Zhong, JZ Ye, K Wang, BC Xing, LQ Li Annals of surgery 274 (6), e1209-e1217, 2021 | 65 | 2021 |
| Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension JH Zhong, Y Ke, YY Wang, LQ Li Gut 64 (3), 520-521, 2015 | 65 | 2015 |
| Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion YP Qi, JH Zhong, ZY Liang, J Zhang, B Chen, CZ Chen, LQ Li, BD Xiang The American Journal of Surgery 217 (4), 739-744, 2019 | 64 | 2019 |
| Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis JH Zhong, XM You, WF Gong, L Ma, Y Zhang, QG Mo, LC Wu, J Xiao, ... PloS one 7 (3), e32159, 2012 | 62 | 2012 |
Prof. Alessandro Cucchetti MDDepartment of Medical and Surgical Sciences; University of BolognaVerified email at unibo.it
